Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Insects|December 3, 2020
Quantification and Impact of Cold Storage and Heat Exposure on Mass Rearing Program of <i>Bactrocera dorsalis</i> (Diptera:Tephritidae) Genetic Sexing StrainJia Lin, Hanano Yamada, Ningfeng Lu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 20, 2025
Neuropeptide Ecdysis-Triggering Hormone and Its Receptor Mediate the Fecundity Improvement of 'Candidatus Liberibacter Asiaticus'-Infected Diaphorina citri Females and CLas ProliferationXiaoge Nian, Bo Wang, Paul Holford, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 22, 2014
In vivo powering of pacemaker by breathing-driven implanted triboelectric nanogeneratorQiang Zheng, Bojing Shi, Fengru Fan, et al.
Gut Microbes|January 18, 2022
Human gut microbiome aging clocks based on taxonomic and functional signatures through multi-view learningYutao Chen, Hongchao Wang, Wenwei Lu, et al.
International Journal of Food Sciences and Nutrition|August 6, 2021
A multiphase dietetic protocol incorporating an improved ketogenic diet enhances weight loss and alters the gut microbiome of obese peopleWeiwei Yuan, Wenwei Lu, Hongchao Wang, et al.
Microbiological Research|March 25, 2025
Role of iturin from Bacillus velezensis DMW1 in suppressing growth and pathogenicity of Plectosphaerella cucumerina in tomato by reshaping the rhizosphere microbial communitiesQian Zhao, Qurban Ali, Weiwei Yuan, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 1, 2024
BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancerWeiwei Yuan, Qiyue Zhang, Yuhan Zhao, et al.
European Journal of Medical Research|November 14, 2025
Pan-cancer analysis identifies LMBR1L as a prognostic and immunological biomarker with validation in colorectal cancerSong Liang, Weiwei Yuan, Yin Shi, et al.
Molecular Medicine Reports|September 18, 2020
Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cellsHongyu Xu, Hui Gao, Hua Li, et al.
Oncotargets and Therapy|February 6, 2020
Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three CasesHongyu Xu, Lin Zhou, You Lu, et al.
Pageof 9